| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.73B | 58.40B | 55.64B | 51.40B | 69.46B | 59.93B |
| Gross Profit | 10.00B | 10.29B | 10.10B | 10.22B | 11.24B | 9.68B |
| EBITDA | 4.61B | 4.20B | 4.74B | 5.06B | 6.06B | 4.33B |
| Net Income | 3.17B | 3.17B | 3.05B | 2.99B | 3.69B | 2.37B |
Balance Sheet | ||||||
| Total Assets | 26.32B | 27.60B | 25.54B | 23.87B | 24.89B | 23.52B |
| Cash, Cash Equivalents and Short-Term Investments | 13.60B | 14.17B | 14.08B | 14.50B | 15.37B | 12.65B |
| Total Debt | 159.00M | 145.00M | 383.00M | 442.00M | 1.98B | 2.96B |
| Total Liabilities | 6.43B | 6.74B | 6.06B | 6.02B | 8.28B | 9.38B |
| Stockholders Equity | 19.42B | 20.50B | 19.05B | 17.51B | 16.32B | 13.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.50B | 3.15B | 3.13B | 5.26B | 3.77B |
| Operating Cash Flow | 0.00 | 3.53B | 3.23B | 3.17B | 5.32B | 3.77B |
| Investing Cash Flow | 0.00 | -1.62B | -1.88B | -201.00M | 167.00M | 396.00M |
| Financing Cash Flow | 0.00 | -2.19B | -2.11B | -4.06B | -2.81B | -2.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥51.76B | 16.96 | ― | 3.98% | 4.96% | 4.20% | |
73 Outperform | ¥77.23B | 6.51 | ― | 3.48% | 2.70% | 38.48% | |
68 Neutral | ¥75.84B | 9.20 | ― | 3.63% | 1.18% | 10.99% | |
67 Neutral | ¥284.99B | 19.07 | ― | 2.94% | 4.66% | 72.15% | |
66 Neutral | ¥311.06B | 12.68 | 8.30% | 2.50% | 5.83% | -6.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥304.37B | 20.24 | ― | 1.28% | 7.07% | -8.89% |